All In MedTech

Device Trial Radar · NCT06614582

Long-term Evaluation of Nasopharyngeal Airway in Hypotonia

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

40

Planned (sponsor's estimate)

Start

Oct 23, 2024

Primary completion

Oct 2028

Study completion Oct 2028

Sponsor

Lead sponsor
University of MichiganAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 26, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 3 years, up to 23 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This research is studying the long term use of a nasal airway device (self-supporting nasopharyngeal airway; "ssNPA") in children with hypotonic upper airway obstruction to learn about its effectiveness and tolerability as a treatment for obstructive sleep apnea.

Conditions

  • Hypotonia, Muscle
  • Obstructive Sleep Apnea
  • Nasal Airway Obstruction

Interventions

  • Self-Supporting Nasopharyngeal Airway (ssNPA)Device

    The ssNPA device is a flexible, medical-grade silicone, nasal tube that is self-inserted into the airway through one nostril and worn during the night. It can also be used during the day. The device works by supporting collapsed airway muscles and keeping the airway open. In addition to wearing the device, study team members will call monthly and collect certain data, and medical information and participants will be asked to have a sleep study at the 12-month visit.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Obstructive sleep apnea (OSA) severity measured by the apnea/hypopnea index (AHI) assessed by overnight polysomnographyTime frame: Approximately 1 year
  2. Long term device tolerability assessed by self-report from caregiversTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Michigan

    Ann Arbor, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.